Gilead Sciences

Step 1: Identify a novel drug target involved in HIV replication.

Step 2: Design and synthesize drug candidates that inhibit the target.

Step 3: Conduct preclinical studies to evaluate drug efficacy and safety.

Step 4: Initiate clinical trials to assess the drug's performance in humans.

Step 1: Understand viral replication and host immune responses.

Step 2: Identify direct-acting antivirals (DAAs) inhibiting viral replication.

Step 3: Perform clinical studies of DAAs in infected patients.

Step 4: Monitor long-term efficacy and safety of treatment.

Step 1: Identify novel cancer targets.

Step 2: Develop targeted therapies or immunotherapies.

Step 3: Conduct preclinical and clinical studies.

Step 4: Monitor patient responses and adjust treatment.

Step 1: Identify key inflammatory pathways.

Step 2: Develop drugs targeting these pathways.

Step 3: Perform preclinical and clinical trials.

Step 4: Assess drug efficacy and manage side effects.

Step 1: Identify unmet healthcare needs in specific communities.

Step 2: Develop targeted interventions and programs.

Step 3: Collaborate with community organizations.

Step 4: Monitor program effectiveness and expand reach.